Erytech Pharma SA (NASDAQ:ERYP)
| 0.59 Delayed Data As of Jan 27 |  +0.0195 / +3.42%Today’s Change | 0.30 Today|||52-Week Range 2.18 | +78.73% Year-to-Date |
Latest ERYP News | Press Releases
No recent news for Erytech Pharma SA.
Today’s Trading
| Previous close | 0.57 |
| Today’s open | 0.59 |
| Day’s range | 0.52 - 0.60 |
| Volume | 905 |
| Average volume (3 months) | 30,467 |
| Market cap | $18.6M |
Data as of 11:59am ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | +40.94% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -17.40% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALIMAlimera Sciences Inc | 0.00 | 0.00% |
| APMAptorum Group Ltd | +0.02 | +0.39% |
| CRBPCorbus Pharmaceutica... | +0.00 | +3.29% |
| KZIAKazia Therapeutics L... | -0.01 | -1.01% |
Data as of 3:59pm ET, 01/27/2023
Financials
| Next reporting date | March 13, 2023 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$63.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Lyon, Auvergne-rhone-alpes |
Forecasts
